Richtig G, Wolf M, Schulter G, et al. Body-Mass-Index as a predictive marker for response in patients with metastatic melanoma treated with ipilimumab. SMR 2017, P01-15.
Doorbraak in behandeling van maag- en slokdarmkanker
jan 2024 | Immuuntherapie, Maag-darm-leveroncologie